Kurtz Ronald M MDinsider trades
In SEC Form 4 filings, Kurtz Ronald M MD is listed as Chief Medical Officer of RxSight, Inc. (RXST). In the last 90 days, Kurtz Ronald M MD sold $35.5K of RxSight, Inc. (RXST) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RXSTRxSight, Inc. | Chief Medical Officer | 11 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | D · derivative | 338,819 | $16.00 | $5,421,104 | not reported | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | D · derivative | 200,000 | $14.95 | $2,990,000 | not reported | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | D · derivative | 149,000 | $56.07 | $8,354,430 | not reported | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | D · derivative | 215,000 | $28.21 | $6,065,150 | not reported | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | A · derivative | 254,751 | $6.38 | $1,624,038 | 254,751 | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | A · derivative | 173,913 | $6.38 | $1,108,695 | 173,913 | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | A · derivative | 96,129 | $6.38 | $612,822 | 96,129 | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | A · derivative | 161,654 | $6.38 | $1,030,544 | 161,654 | No | Form 4 |
| RXSTRxSight, Inc. | Sep 2 | Sep 2 | S | 5,100 | $6.96 | Sale −$35,496 | 71,775 | No | Form 4 |
| RXSTRxSight, Inc. | Aug 31 | Sep 2 | M | 13,425 | not reported | not reported | 76,875 | No | Form 4 |
| RXSTRxSight, Inc. | Aug 31 | Sep 2 | M · derivative | 13,425 | $0.00 | $0 | 67,120 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.